Equities

J B Chemicals and Pharmaceuticals Ltd

JBCHEPHARM:NSI

J B Chemicals and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,650.40
  • Today's Change7.50 / 0.46%
  • Shares traded147.34k
  • 1 Year change+68.42%
  • Beta0.1679
Data delayed at least 15 minutes, as of Mar 28 2024 10:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.

  • Revenue in INR (TTM)33.85bn
  • Net income in INR5.14bn
  • Incorporated1976
  • Employees5.10k
  • Location
    J B Chemicals and Pharmaceuticals LtdCnergy It Park, Appa Saheb Marathe MargMUMBAI 400025IndiaIND
  • Phone+91 2 224395200
  • Fax+91 2 224395500
  • Websitehttps://jbpharma.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Piramal Pharma Ltd77.82bn-333.40m161.25bn6.30k----23.182.07-0.3002-0.300263.15--------12,362,800.00--------64.29---0.4284----6.36----7.97---149.60------
Suven Pharmaceuticals Ltd11.68bn3.71bn162.91bn1.17k43.91--38.7913.9514.5814.5845.91--------10,023,860.00--------58.68--31.76----86.09----1.52---9.37------
Natco Pharma Ltd.38.28bn12.78bn174.36bn3.98k13.74--12.024.5570.8470.84212.24--------9,621,513.00--10.34--12.0478.2675.1133.3822.66--90.50--21.3439.204.22320.760.5428-19.11-8.34
Sanofi India Ltd28.51bn6.03bn183.34bn3.53k30.4118.0628.546.43261.78261.781,237.96440.801.512.2421.86--31.8422.4250.3530.2157.8855.6921.1521.030.897449.470.018458.182.920.573-2.859.64-10.3414.73
Piramal Enterprises Ltd79.98bn-20.16bn187.82bn12.22k------2.35-90.77-90.77339.88--------6,545,270.00--3.41--4.5147.2988.04-25.2126.30--0.2287--22.746.82-4.74528.3114.25-24.794.90
Pfizer Ltd22.19bn5.02bn192.34bn1.70k38.31--33.338.67109.76109.76485.08--------13,038,660.00--13.81--17.6363.0861.2122.6323.22--50.30--84.31-7.134.131.8611.62-8.7511.84
Alembic Pharmaceuticals Ltd61.18bn5.90bn193.57bn14.59k32.80--22.083.1630.0230.02311.22--------4,192,490.00--11.45--15.3971.1066.439.8013.65--10.21--25.266.5412.54-34.35-3.69-11.6114.87
Laurus Labs Ltd49.82bn1.88bn211.38bn5.75k112.84--37.124.243.483.4892.17--------8,659,934.00--11.78--19.7551.7348.414.0214.16--2.50--12.3722.3923.90-4.5236.3620.4231.95
J B Chemicals and Pharmaceuticals Ltd33.85bn5.14bn254.97bn5.10k50.34--39.627.5332.6332.63214.87--------6,643,323.00--15.37--18.1865.8360.2015.1915.49--15.00--31.7329.9117.366.3524.2683.8454.75
Glenmark Pharmaceuticals Ltd117.51bn-12.31bn271.59bn15.56k------2.31-43.61-25.22416.16--------7,553,779.00--4.65--6.4661.0860.78-9.726.46--1.10--10.17-5.864.94-118.02---10.274.56
Ajanta Pharma Ltd40.36bn7.36bn276.20bn7.71k37.66--31.756.8458.2458.24319.08--------5,233,334.00--16.13--19.5274.1674.0118.2319.22--100.64--15.9312.0211.92-17.504.64-7.86--
Syngene International Ltd35.66bn5.00bn285.31bn6.85k57.19--31.338.0012.4512.4588.72--------5,208,267.00--8.80--11.9571.3670.6814.0317.00--6.88----22.6117.5417.338.747.340.00
Gland Pharma Ltd49.12bn6.59bn299.86bn4.59k45.53--31.626.1039.9839.98298.11--------10,713,810.00--15.16--16.6960.5453.9713.4126.07--46.26--0.00-17.6417.43-35.5419.4621.24--
IPCA Laboratories Ltd71.86bn5.64bn305.79bn16.17k54.18--32.674.2622.2522.25283.32--------4,444,876.00--11.95--15.3465.4759.178.4513.77--12.99--12.027.1113.72-46.6914.5129.3251.57
Biocon Ltd146.13bn12.00bn307.05bn3.41k25.58--10.182.1010.0310.03122.21--------42,877,050.00--4.31--5.9167.1761.3410.1910.87--1.66--8.4936.5422.03-28.644.4413.5024.57
GlaxoSmithKline Pharmaceuticals Limited33.11bn5.29bn318.45bn3.68k60.19--53.289.6231.2331.23195.53--------8,998,269.00--9.94--16.0160.3754.7115.9711.58--447.28--196.13-0.80252.3559.5811.62-35.7912.83
Data as of Mar 28 2024. Currency figures normalised to J B Chemicals and Pharmaceuticals Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

15.97%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 29 Feb 20244.89m3.15%
Axis Asset Management Co. Ltd.as of 15 Mar 20244.12m2.66%
Abrdn Asia Ltd.as of 21 Mar 20242.83m1.82%
The Vanguard Group, Inc.as of 07 Mar 20242.69m1.73%
Norges Bank Investment Managementas of 30 Jun 20232.47m1.59%
Invesco Asset Management (India) Pvt Ltd.as of 29 Feb 20242.01m1.30%
Canara Robeco Asset Management Co. Ltd.as of 15 Mar 20241.74m1.12%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 29 Feb 20241.59m1.02%
Edelweiss Asset Management Ltd.as of 29 Feb 20241.31m0.84%
HSBC Asset Management (India) Pvt Ltd.as of 29 Feb 20241.13m0.73%
More ▼
Data from 31 Dec 2023 - 21 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.